Herlen Alencar
- Biomedical Engineering top 10%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 5%
- Oncology top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Umar MahmoodRalph WeisslederMartin FunovicsKimberly M. KellyJose‐Luiz FigueiredoXavier MontetSushma GurumurthyNabeel Bardeesy
- Topics
- Monoclonal and Polyclonal Antibodies Research (5 papers)Nanoplatforms for cancer theranostics (4 papers)Glycosylation and Glycoproteins Research (3 papers)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Herlen Alencar
18 papers receiving 966 citations
Peers
Comparison fields: 5 of 81
- Biomedical Engineering 292
- Molecular Biology 289
- Radiology, Nuclear Medicine and Imaging 254
- Oncology 235
- Pulmonary and Respiratory Medicine 168
Countries citing papers authored by Herlen Alencar
This map shows the geographic impact of Herlen Alencar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herlen Alencar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herlen Alencar more than expected).
Fields of papers citing papers by Herlen Alencar
This network shows the impact of papers produced by Herlen Alencar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herlen Alencar. The network helps show where Herlen Alencar may publish in the future.
Co-authorship network of co-authors of Herlen Alencar
This figure shows the co-authorship network connecting the top 25 collaborators of Herlen Alencar. A scholar is included among the top collaborators of Herlen Alencar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herlen Alencar. Herlen Alencar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 52 | |
| 4 | 184 | |
| 5 | 75 | |
| 6 | 2 | |
| 7 | 92 | |
| 8 | 1 | |
| 9 | 148 | |
| 10 | 39 | |
| 11 | 45 | |
| 12 | 36 | |
| 13 | 45 | |
| 14 | 26 | |
| 15 | 55 | |
| 16 | 104 | |
| 17 | 14 | |
| 18 | 59 |
About Herlen Alencar
Herlen Alencar is a scholar working on Transplantation, Radiology, Nuclear Medicine and Imaging and Biotechnology, having authored 18 papers that have together received 979 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Nanoplatforms for cancer theranostics (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (254 citations), Biotechnology (91 citations) and Biophysics (55 citations). Herlen Alencar has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Umar Mahmood, Ralph Weissleder, Martin Funovics, Kimberly M. Kelly, Jose‐Luiz Figueiredo, Xavier Montet, Sushma Gurumurthy, Nabeel Bardeesy, Justin H. Berger and Ronald A. DePinho. Their work appears in journals such as Nature Immunology, Cancer Research and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.